A Phase II Study of the FIL on Elderly Frail Patients With DLBCL
Condition(s):Diffuse Large B-cells Non-Hodgkin LymphomaLast Updated:December 23, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B-cells Non-Hodgkin LymphomaLast Updated:December 23, 2022Completed
Condition(s):Multiple MyelomaLast Updated:June 26, 2018Completed
Condition(s):Multiple MyelomaLast Updated:June 29, 2023Completed
Condition(s):Leukemia, Lymphocytic, Chronic, B-Cell; Chronic Lymphocytic Leukemia; Lymphoma, Small LymphocyticLast Updated:August 13, 2014Terminated
Condition(s):Refractory Differentiated Thyroid Gland Carcinoma; Refractory Thyroid Gland Follicular Carcinoma; Refractory Thyroid Gland Hurthle Cell Carcinoma; Refractory Thyroid Gland Papillary Carcinoma; Unresectable Thyroid Gland CarcinomaLast Updated:July 15, 2021Completed
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:May 22, 2023Completed
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:November 18, 2020Completed
Condition(s):Primary Systemic AmyloidosisLast Updated:April 25, 2017Completed
Condition(s):Multiple Myeloma; Myeloma-Associated AmyloidosisLast Updated:January 9, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:December 9, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.